Effects of 9-amino- 1,2,3,4-tetrahydroacridine (THA) on ATP diphosphohydrolase (EC 3.6.1.5) and 5'-nucleotidase (EC 3.1.3.5) from rat brain synaptosomes

General Pharmacology

Volumn 28, Issue 5, 1997, Pages 761-766

  Bonan, Carla D ^a   Battastini, Ana M O ^a   Schetinger, Maria Rosa C ^b   Moreira, Cleci M ^c   Frassetto, Silvana S ^a   Dias, Renato D ^a   Sarkis, João J F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Centre of Natural and Exact Sciences   (Brazil)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

5' nucleotidase; 9 amino 1,2,3,4 tetrahydroacridine; Alzheimer's disease; apyrase; ATP diphosphohydrolase; THA

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; 5' NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; APYRASE; CHOLINESTERASE INHIBITOR; EDETIC ACID; SODIUM AZIDE; SUCROSE; TACRINE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; APYRASE; BRAIN; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; HIPPOCAMPUS; HYDROLYSIS; KINETICS; MALE; RATS; RATS, WISTAR; SYNAPTOSOMES; TACRINE;

EID: 0030970994     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00276-5     Document Type: Article

References (46)

1. Adem A., Jossan S. S. and Oreland L. (1989) Tetrahydroaminoacridine inhibits human and rat brain monoamino oxidase. Neurosci. Lett. 107, 313-319.
2. Bartus R. T., Dean R. L., Beer B. and Lippa A. S. (1982) The cholinergic hypothesis of geriatric memory disfunction. Science 217, 408-417.
3. Battastini A. M. O., Rocha J. B. T., Barcellos C. K., Dias R. D. and Sarkis J. J. F. (1991) Characterization of an ATP diphosphohydrolase (EC 3.6.1.5) in synaptosomes from cerebral cortex of adult rats. Neurochem. Res. 16, 1303-1310.
4. Battastini A. M. O., Oliveira E. M., Moreira C. M., Bonan C. D., Sarkis J. J. F. and Dias R. D. (1995) Solubilization and characterization of an ATP diphosphohydrolase (EC 3.6.1.5) from rat brain synaptic plasma membranes. Biochem. Mol. Biol. Int. 37, 209-219.
5. Bradford M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 218-254.
6. 2 purine receptors regulate striatal acetylcholine release. J. Neurochem. 55, 31-38.
7. Burnstock G. (1972) Purinergic nerves. Pharmacol. Rev. 24, 509-581.
8. Burnstock G. (1986) The changing face of autonomic transmission. Acta Physiol. Scand. 126, 76-91.
9. Burnstock G. (1993) Physiological and pathological roles of purines: an update. Drug Dev. Res. 28, 195-206.
10. +2-ATPase activity. Anal. Biochem. 157, 375-380.
11. Cornish-Bowden A. (1974) A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem. J. 137, 143-144.
12. Cumming P., Reiner P. B. and Vicent S. R. (1990) Inhibition of rat brain histamine N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA). Biochem. Pharmacol. 40, 1145-1150.
13. Da Prada M. and Pletscher A. (1968) Isolated 5-hydroxytryptamine organelles of rabbit blood platelets. Physiological properties and drug-induced changes. Br. J. Pharmacol. 34, 591-597.
14. Dawson R. M. and Poretski M. (1991) The interaction of tacrine with benzoadiazepine and GABA binding sites of guinea pig brain. Neurosci. Lett. 129, 251-256.
15. Dixon M. and Webb E. C. (1964) Enzymes, 2nd edn, p. 950. Longmans, London.
16. + current. Eur. J. Pharmacol. 141, 153-157.
17. Drukarch B., Leysen J. E. and Stoof J. C. (1988) Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease. Life Sci. 42, 1011-1017.
18. Edwards F. A., Gibb A. J. and Colquhoun D. (1992) ATP receptor-mediated synaptic currents in the central nervous system. Nature 359, 144-147.
19. Elinder F. and Arhem P. (1991) Mechanisms of tetrahydroaminoacridine effect on action potential and ion currents in myelinated axons. Eur. J. Pharmacol. 208, 1-6.
20. Evans R. J., Derkach V. and Surprenant A. (1992) ATP mediates fast synaptic transmission in mammalian neurons. Nature 357, 503-505.
21. Farlow M., Gracon S. I., Hershey L. A., Lewis K. W., Sadowski C. H. and Dolan-Ureno J. (1992) A controlled trial of Tacrine in Alzheimer's disease. JAMA 268, 2523-2529.
22. Flynn D. D. and Mash D. C. (1989) Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. J. Pharmacol. Exp. Ther. 250, 573-581.
23. Heymann D., Reddington M. and Kreutzberg G. W. (1984) Subcellular localization of 5′-nucleotidase in rat brain. J. Neurochem. 43, 971-978.
24. Hunter A. J., Murray T. K., Jones J. A., Cross A. J. and Green A. R. (1989) The cholinergic pharmacology of tetrahydroacridine in vivo and in vitro. Br. J. Pharmacol. 98, 79-86.
25. Knapp M. J., Knopman D. S., Solomon P. R., Pendlebury W. W., Davis C. S. and Gracon S. I. (1994) A 30-week randomized controlled trial of high-dose Tacrine in patients with Alzheimer's disease. JAMA 271, 985-991.
26. Müller J., Rocha J. B. T., Battastini A. M. O., Kuplich C. B., Sarkis J. J. F. and Dias R. D. (1990) Ontogenesis of ATP and ADP hydrolysis activity in synaptosomal fractions from cerebral cortex of rats. Braz. J. Med. Biol. Res. 23, 935-939.
27. Nagy A. and Delgado-Escueta A. V. (1984) Rapid preparation of synaptosomes from mammalian brain using nontoxic isoosmotic gradient (Percoll). J. Neurochem. 43, 1114-1123.
28. Oliveira E. M., Rocha J. B. T. and Sarkis J. J. F. (1994) In vitro and in vivo effects of synaptosomal ATP diphosphohydrolase (EC 3.6.1.5) from cerebral cortex of developing rats. Arch. Int. Phys. Biochim. Biophys. 102, 251-254.
29. Potter P. and White T. D. (1980) Release of adenosine and adenosine 5′-triphosphate from synaptosomes from different regions of rat brain. Neuroscience 5, 1351-1356.
30. Reiner P. B. and Mc Geer E. G. (1988) THA increases action potential duration of central histamine neurons in vitro, Eur J. Pharmacol. 155, 265-270.
31. Reisberg B., Ferris S. H., De Leon M. J. and Crook T. (1982) The global deterioration scale for assessment of primary degenerative dementia. Am. J. Psychiatry 139, 1136-1139.
32. Richardson P. J. and Brown S. J. (1987) ATP release from affinity-purified rat cholinergic nerve terminals. J. Neurochem. 48, 622-630.
33. Rocha J. B. T., Mello C. F., Sarskis J. J. F. and Dias R. D. (1990) Undernutrition during the preweaning period changes calcium ATPase and ADPase activities of synaptosomal fractions of weaning rats. Br. J. Nutr. 63, 273-284.
34. Sarkis J. J. F. and Saltó C. (1991) Characterization of a synaptosomal ATP diphosphohydrolase from the electric organ of Torpedo marmorata. Brain Res. Bull. 26, 871-876.
35. Schadeck R. J. G., Sarskis J. J. F., Dias R. D., Araujo H. M. M. and Souza D. O. G. (1989) Synaptosomal apyrase in the hypothalamus of adult rats. Braz. J. Med. Biol. Res. 22, 303-314.
36. Schetinger M. R. C., Barcellos C. K., Barlem A., Zwestch G., Gubert A., Bertuol C., Arteni N., Dias R. D., Sarskis J. J. F. and Netto C. A. (1994) Activity of synaptosomal ATP diphosphohydrolase from hippocampus of rats tolerant to forebrain ischemia. Braz. J. Med. Biol. Res. 27, 1123-1128.
37. Schetinger M. R. C., Wyse A. T., Silva L. B., Barcellos C. K., Dias R. D. and Sarkis J. J. F. (1995) Effect of aluminum chloride on the kinetics of rat cortex synaptosomal ATP diphosphohydrolase (EC 3.6.1.5). Biol. Trac. Elem. Res. 50, 209-220.
38. Silinski E. M. (1984) On the mechanism by which adenosine receptor activation inhibits the release of acetylcholine from motor nerve endings. J. Physiol. (Lond) 346, 243-256.
39. Stone T. W. (1981) Physiological roles for adenosine and ATP in the nervous system. Neuroscience 6, 523-555.
40. Summers W. K., Majowski L. V., Marsh G. M., Tachiki K. and Kling A. (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315, 1241-1245.
41. 11]methyl-tetrahydroaminoacridine (methyl-tacrine) in baboon brain. Eur. J. Pharmacol. 236, 229-238.
42. Vietta, M., Frassetto S. S., Battastini A. M. O., Belló-Klein A., Moreira C. M., Dias R. D. and Sarkis J. J. F. (1996) Sensitivity of ATPase-ADPase activities from synaptic plasma membranes of rat forebrain to lipid peroxidation in vitro and the protective effect of Vitamin E. Neurochem. Res. 21, 299-304.
43. Wang S. J., Huang C. C. and Gean P. W. (1995) Tetrahydro-9-aminoacridine presynaptically inhibits glutamatergic transmission in the rat amygdala. Brain Res. Bull. 37, 325-327.
44. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T. and De Long M. R. (1982) Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215, 1237-1239.
45. Williams M. (1984) Adenosine - a selective neuromodulator in the mammalian CNS? Trends Neurosci. 7, 164-168.
46. Ziganshin A. U., Hoyle C. H. V. and Burnstock G. (1994) Ecto-enzymes and metabolism of extracellular ATP. Drug. Dev. Res. 32, 134-136.